O'Brien Kristal, Saravanabavan Sayanthooran, Zhang Jennifer Q J, Wong Annette T Y, Munt Alexandra, Burgess Jane S, Rangan Gopala K
Centre for Transplant and Renal Research, Westmead Institute for Medical Research, The University of Sydney, Sydney, New South Wales, Australia.
Department of Renal Medicine, Westmead Hospital, Western Sydney Local Health District, Sydney, New South Wales, Australia.
Int J Nephrol Renovasc Dis. 2020 Apr 1;13:53-64. doi: 10.2147/IJNRD.S238767. eCollection 2020.
BACKGROUND/AIM: The natural history of the renal microvasculature changes in PKD is not known. The aim of this study was to test the hypothesis that angiogenesis is coupled with kidney cyst expansion, and the loss of peritubular capillary networks precedes the onset of interstitial fibrosis.
The renal microvasculature (RECA-1 and CD34) was evaluated in groups of Lewis polycystic kidney (LPK) rats and juvenile cystic kidney () mice during the early, mid and late stage of disease. In addition, LPK rats and mice received sirolimus to determine if the reduction in renal cyst growth is in part mediated by the suppression of angiogenesis.
In LPK rats, the loss of peritubular capillaries occurred in early-stage disease and paralleled cyst formation whereas in mice it was delayed to the mid stage. In both models, vasa recta were displaced by growing cysts and regressed in LPK rats with disease progression but lengthened in mice. Cortical and medullary capillary neoangiogenesis occurred during the early stage in both models and persisted with progression. Treatment with sirolimus reduced cyst enlargement but did not alter the progression of renal microvasculature changes in either model.
Regression of peritubular capillaries and disruption of vasa recta occur in parallel with angiogenesis and the progressive enlargement of kidney cysts. These data suggest that the regrowth of peritubular capillaries together with inhibition of angiogenesis are potential strategies to be considered in the treatment of PKD.
背景/目的:多囊肾病(PKD)肾微血管变化的自然病程尚不清楚。本研究的目的是验证以下假设:血管生成与肾囊肿扩大相关,且肾小管周围毛细血管网的丧失先于间质纤维化的发生。
在疾病的早期、中期和晚期,对Lewis多囊肾(LPK)大鼠和幼年多囊肾( )小鼠组的肾微血管(RECA-1和CD34)进行评估。此外,给LPK大鼠和 小鼠使用西罗莫司,以确定肾囊肿生长的减少是否部分由血管生成的抑制介导。
在LPK大鼠中,肾小管周围毛细血管的丧失发生在疾病早期,与囊肿形成平行,而在 小鼠中则延迟到中期。在两种模型中,直小血管都被生长的囊肿移位,在LPK大鼠中随着疾病进展而退化,但在 小鼠中延长。在两种模型的早期都发生了皮质和髓质毛细血管新生血管形成,并随着进展持续存在。西罗莫司治疗可减少囊肿扩大,但在两种模型中均未改变肾微血管变化的进展。
肾小管周围毛细血管的退化和直小血管的破坏与血管生成和肾囊肿的逐渐扩大同时发生。这些数据表明,肾小管周围毛细血管的再生以及血管生成的抑制是治疗PKD时可考虑的潜在策略。